ClinicalTrials.gg
Sign In

DrugBiological

Recombinant Granulocyte Colony-Stimulating Factor clinical trials

studies test it
7
open now
2
in phase 3
2
first study started
2011

Keep track of what changes. Save the Recombinant Granulocyte Colony-Stimulating Factor studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

rhG-CSF
3
Pegylated rhG-CSF: 6mg
2
Recombinant Granulocyte Colony-Stimulating Factor
2
Recombinant Colony-Stimulating Factor 3
2

Studies by the year they started

7 studies that test it; most in 2012 (2)

Studies that test Recombinant Granulocyte Colony-Stimulating Factor, by start year
YearStudies
20111
20122
20191
20201
20211
20251

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms
2
Hodgkin Disease
1
Lymphoma
1
Lymphoma, Non-Hodgkin
1
Febrile Neutropenia
1

Who runs them

Industry 3 · Other 4

Jiangsu HengRui Medicine Co., Ltd. (3) · Fred Hutchinson Cancer Center (1) · City of Hope Medical Center (1) · The First Hospital of Jilin University (1) · Ruijin Hospital (1)

Often tested with

Tested in the same studies.

Cytarabine (2) · Fludarabine (1) · Idarubicin (1) · Peripheral Blood Stem Cell (1) · Basiliximab (1) · Carmustine (1) · Etoposide (1) · Genetically Engineered Hematopoietic Stem Progenitor Cells (1)

Studies

Open first, then newest update. How each study uses Recombinant Granulocyte Colony-Stimulating Factor is read from its arms, and is right about nine times in ten.

Testing it · 7

Given in every arm · 9 — Recombinant Granulocyte Colony-Stimulating Factor is usual care beside what is tested
As the comparator · 10 — what is tested is compared with Recombinant Granulocyte Colony-Stimulating Factor